Old Web
English
Sign In
Acemap
>
authorDetail
>
Bin Chen
Bin Chen
Janssen Pharmaceutica
Antagonist
Histamine H4 receptor
Placebo
Histamine
Medicine
4
Papers
129
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 2a, randomized, double‐blind, placebo‐controlled, multicentre, parallel‐group study of an H4R‐antagonist (JNJ‐39758979) in adults with uncontrolled asthma
2018
Clinical & Experimental Allergy
Alexa P. Kollmeier
Andrew Greenspan
Xie Xu
Philip E. Silkoff
Elliot S. Barnathan
Matthew J. Loza
J.Z. Jiang
Bei Zhou
Bin Chen
Robin L. Thurmond
Show All
Source
Cite
Save
Citations (6)
Toreforant, A Histamine H4 Receptor Antagonist, in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of 2 Phase II Studies
2016
The Journal of Rheumatology
Robin L. Thurmond
Andrew Greenspan
Waldemar Radziszewski
Xie L. Xu
Ye Miao
Bin Chen
Ting Ting Ge
Bei Zhou
Daniel Baker
Dace Pavlova
Christopher T. Ritchlin
Yoshiya Tanaka
Tsutomu Takeuchi
Josef S. Smolen
Show All
Source
Cite
Save
Citations (14)
Clinical and Preclinical Characterization of the Histamine H 4 Receptor Antagonist JNJ 39758979
2014
Journal of Pharmacology and Experimental Therapeutics
Robin L. Thurmond
Bin Chen
Paul J. Dunford
Andrew Greenspan
Lars Karlsson
David La
Peter Ward
Xie L. Xu
Show All
Source
Cite
Save
Citations (42)
The Histamine H4 Receptor Antagonist, JNJ 39758979, Is Effective in Reducing Histamine-Induced Pruritus in a Randomized Clinical Study in Healthy Subjects
2014
Journal of Pharmacology and Experimental Therapeutics
Alexa P. Kollmeier
Klaus Francke
Bin Chen
Paul J. Dunford
Andrew Greenspan
Yichuan Xia
Xie L. Xu
Bei Zhou
Robin L. Thurmond
Show All
Source
Cite
Save
Citations (67)
1